| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-23 | Bonita David P Director, 10% Owner | Purchase | +2,815,315 | -88.87%1,126,126 | $4.44 | $12,499,999 | View SEC filing | |
| 2026-04-23 | ORBIMED ADVISORS LLC Director, 10% Owner | Purchase | +2,815,315 | -88.87%1,126,126 | $4.44 | $12,499,999 | View SEC filing | |
| 2026-04-22 | BAKER JULIAN Director, 10% Owner | Purchase | +2,252,252 | +1185.82%20,105,994 | $4.44 | $9,999,774 | View SEC filing | |
| 2025-03-27 | Combs Andrew Chief Chemistry Officer | Purchase | +100,000 | +26.31%480,123 | $0.69 | $69,250 | View SEC filing | |
| 2025-03-27 | Vaddi Krishna CEO | Purchase | +675,000 | +50.97%1,999,296 | $0.69 | $467,438 | View SEC filing | |
| 2025-03-24 | Vaddi Krishna CEO | Purchase | +20,416 | +1.57%1,324,296 | $0.73 | $14,909 | View SEC filing | |
| 2025-03-18 | Vaddi Krishna CEO | Purchase | +39,105 | +3.09%1,303,880 | $0.75 | $29,460 | View SEC filing | |
| 2025-03-14 | Vaddi Krishna CEO | Purchase | +97,500 | +8.35%1,264,775 | $0.71 | $69,564 | View SEC filing | |
| 2025-01-03 | Vaddi Krishna CEO | Purchase | +5,000 | +3.63%142,553 | $1.21 | $6,044 | View SEC filing | |
| 2025-01-02 | Vaddi Krishna CEO | Purchase | +10,000 | +7.84%137,553 | $1.20 | $12,000 | View SEC filing | |
| 2024-12-26 | Combs Andrew Chief Chemistry Officer | Purchase | +63,075 | +20.05%377,623 | $1.36 | $85,538 | View SEC filing | |
| 2024-12-20 | Lim Bryant David CLO, Interim CFO, Corp Sec. | Purchase | +25,000 | +1041.67%27,400 | $0.91 | $22,638 | View SEC filing | |
| 2024-12-20 | Vaddi Krishna CEO | Purchase | +106,888 | +9.00%1,294,828 | $0.93 | $99,326 | View SEC filing | |
| 2023-05-26 | Vaddi Krishna CEO | Purchase | +1,900 | +0.18%1,067,275 | $5.15 | $9,790 | View SEC filing | |
| 2023-05-25 | Lim Bryant David Chief Legal Officer, Corp Sec. | Purchase | +2,400 | +100.00%2,400 | $5.39 | $12,936 | View SEC filing | |
| 2023-05-25 | Chardonnet Laurent Chief Financial Officer | Purchase | +5,000 | +13.45%42,165 | $5.50 | $27,500 | View SEC filing | |
| 2023-05-25 | Vaddi Krishna CEO | Purchase | +11,856 | +1.13%1,065,375 | $5.63 | $66,749 | View SEC filing | |
| 2023-05-24 | ORBIMED ADVISORS LLC Director, 10% Owner | Purchase | +869,565 | +9.40%10,119,756 | $5.75 | $4,999,999 | View SEC filing | |
| 2023-05-24 | Bonita David P Director, 10% Owner | Purchase | +869,565 | +9.40%10,119,756 | $5.75 | $4,999,999 | View SEC filing | |
| 2023-04-06 | Huang Jane President, CMO | Sale | -13,280 | -35.41%24,220 | $6.12 | $81,274 | View SEC filing | |
| 2022-12-21 | Vaddi Krishna CEO | Purchase | +19,188 | +18.91%120,665 | $5.13 | $98,446 | View SEC filing | |
| 2022-12-12 | Chardonnet Laurent Chief Financial Officer | Purchase | +10,000 | +38.65%35,873 | $4.76 | $47,600 | View SEC filing | |
| 2022-06-01 | Chardonnet Laurent Chief Financial Officer | Purchase | +10,000 | +68.97%24,500 | $4.23 | $42,300 | View SEC filing | |
| 2021-12-17 | Morosini Deborah EVP, Chief of Clinical Affairs | Sale | -28,751 | -98.48%444 | $13.00 | $373,763 | View SEC filing | |
| 2021-12-15 | Combs Andrew EVP, Head of Chemistry | Purchase | +8,000 | +3.07%268,380 | $11.86 | $94,880 | View SEC filing |
1-25 of 63
